This link has been bookmarked by 1 people . It was first bookmarked on 09 Jul 2008, by David Dobbs.
-
09 Jul 08
-
The recent surge in funding started as a direct
consequence of the HIV/AIDS pandemic -
The revolution started at an international
AIDS meeting in Vancouver, Canada, in 1996. Scientists presented exhilarating evidence
that a combination of anti-HIV drugs (known as antiretrovirals, or ARVs) could dramatically
reduce the spread of the virus inside the bodies of infected people and make it
possible for them to live long lives. Practically overnight, tens of thousands of
infected men and women in wealthy countries started the new treatments, and by mid-1997,
the visible horrors of AIDS had almost disappeared from the United States and Europe.But the drugs, then priced at about
$14,000 per year and requiring an additional $5,000 a year for tests and medical
visits, were unaffordable for most of the world's HIV-positive population. So between
1997 and 2000, a worldwide activist movement slowly developed to address this problem
by putting pressure on drug companies to lower their prices or allow the generic
manufacture of the new medicines. - 5 more annotations...
-
-
And by 1999, total donations
for health-related programs (including HIV/AIDS treatment) in sub-Saharan Africa
hit $865 million -- up more than tenfold in just three years -
In 2001, a group of 128 Harvard University
faculty members led by the economist Jeffrey Sachs estimated that fewer than 40,000
sub-Saharan Africans were receiving ARVs, even though some 25 million in the region
were infected with HIV and perhaps 600,000 of them needed the drugs immediately -
Andrew Natsios, then director of the U.S. Agency for International Development (USAID),
dismissed the idea of distributing such drugs, telling the House International Relations
Committee that Africans could not take the proper combinations of drugs in the proper
sequences because they did not have clocks or watches and lacked a proper concept
of time. The Harvard faculty group labeled Natsios' comments racist and insisted
that, as Sachs put it, all the alleged obstacles to widespread HIV/AIDS treatment
in poor countries "either don't exist or can be overcome," and that three million
people in Africa could be put on ARVs by the end of 2005 at "a cost of $1.1 billion
per year for the first two to three years, then $3.3 billion to $5.5 billion per
year by Year five." -
What seemed a brazen request then has
now, just five years later, actually been eclipsed. HIV/AIDS assistance has effectively
spearheaded a larger global public health agenda. The Harvard group's claim that
three million Africans could easily be put on ARVs by the end of 2005 proved overoptimistic:
the WHO's "3 by 5 Initiative" failed to meet half of the three million target, even
combining all poor and middle-income nations and not just those in Africa. Nevertheless,
driven by the HIV/AIDS pandemic, a marvelous momentum for health assistance has
been built and shows no signs of abating -
In recent years, the generosity of individuals,
corporations, and foundations in the United States has grown by staggering proportions.
As of August 2006, in its six years of existence, the Bill and Melinda Gates Foundation
had given away $6.6 billion for global health programs. Of that total, nearly $2
billion had been spent on programs aimed at TB and HIV/AIDS and other sexually transmitted
diseases. Between 1995 and 2005, total giving by all U.S. charitable foundations
tripled, and the portion of money dedicated to international projects soared 80
percent, with global health representing more than a third of that sum. Independent
of their government, Americans donated $7.4 billion for disaster relief in 2005
and $22.4 billion for domestic and foreign health programs and research.
-
-
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.